<DOC>
	<DOCNO>NCT00969098</DOCNO>
	<brief_summary>Recently , small trial show promising result value fluoro-2-deoxy-D-glucose positron emission tomography image response assessment Malignant Pleural Mesothelioma . These study consider different parameter Positron Emission Tomography ( PET ) analysis , mainly standardize uptake value volume-based parameter total glycolytic volume .</brief_summary>
	<brief_title>Response Evaluation Malignant Pleural Mesothelioma</brief_title>
	<detailed_description>This retrospective analysis two consecutive homogeneous series Malignant Pleural Mesothelioma patient treat first-line pemetrexed-based chemotherapy evaluate CT scan FDG-PET .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<criteria>Histologically proven MALIGNANT PLEURAL MESOTHELIOMA Patients candidate radical surgery Unidimensionally and/or bidimensionally CTmeasurable disease Candidate firstline pemetrexedbased chemotherapy Histologically proven MALIGNANT PLEURAL MESOTHELIOMA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Histologically proven Malignant pleural mesothelioma ;</keyword>
	<keyword>Patients candidate radical surgery ;</keyword>
	<keyword>Candidate first-line pemetrexed-based chemotherapy ;</keyword>
</DOC>